JOIN US

for the 6th International BRCA Forum 19 AUGUST 2022 which will be one of the foremost International Scientific Virtual Forum on Hereditary Cancer
YOUNG WOMEN’S FORUM – 18 AUGUST 2022 | IBRCAF FORUM – 19 AUGUST 2022 | APGCS – 20 &21 AUGUST 2022

The programme is developed to present to both clinicians and researchers the most up-to-date information on hereditary breast and ovarian cancer.

Health professionals and researchers from all over the globe are expected to attend, including primary care physicians, specialist physicians, laboratory researchers, nurses, and genetic counselors who are interested in furthering their knowledge in the field of hereditary breast and ovarian cancer. The program responds to the needs and interests of clinical researchers and specialists in the field, as well as those of primary care providers who want to know more about how to evaluate their patients, and to whom to refer them.

"In Conjunction With"

APMEA

View our Past Events

iBRCAf 2022 is back to Singapore after 2 years and was presented on a Hybrid Format! The 6th Edition of iBRCAf  features Asia-Pacific and Global key opinion leaders discuss and highlight different aspects on sessions like  Precision Oncology, BRCA Associated Tumours: Where are we today? and Molecular Tumor Boards.

The inaugural session of the  5th  iBRCAf kicked of on 13th August which featured 41 speakers and 5 high-level session, the BRCA Forum is one of the foremost International Scientific Virtual Forum on Hereditary Cancer

BRCA

session 1 : The 4th International BRCA Forum was held on 21 AUGUST 2020,  kicked off at 18:00hrs Singapore Time. The session was chaired by John Chia from Singapore, with speakers from Singapore, India, Malaysia, Hong kong and USA

BRCA

Session 2: The 4th International BRCA Forum was held on 21 AUGUST 2020. The session was chaired by Dr. Shona Nag from India, with speakers from Singapore and USA

BRCA

Session 3: The 4th International BRCA Forum was held on 21 AUGUST 2020. The session was chaired by Dr. Nitesh Rohatgi from India, with speakers from Switzerland, the session was followed by the APMEA Tumor Molecular Board: Case Discussion.

Upcoming Events

Disclaimer :

This site does not recommend, endorse or promote any particular management approach, methodology or treating agents. The views expressed by various experts are their own.